BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29431238)

  • 1. Basigin expression as a prognostic indicator in stage I pulmonary adenocarcinoma.
    Matsumoto T; Nagashio R; Ryuge S; Igawa S; Kobayashi M; Fukuda E; Goshima N; Ichinoe M; Jiang SX; Satoh Y; Masuda N; Murakumo Y; Saegusa M; Sato Y
    Pathol Int; 2018 Apr; 68(4):232-240. PubMed ID: 29431238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer.
    Xu XY; Lin N; Li YM; Zhi C; Shen H
    Pathol Res Pract; 2013 Jun; 209(6):345-52. PubMed ID: 23602236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathological significance of Lgr5 expression in lung adenocarcinoma.
    Ryuge S; Sato Y; Jiang SX; Wang G; Kobayashi M; Nagashio R; Katono K; Iyoda A; Satoh Y; Masuda N
    Lung Cancer; 2013 Oct; 82(1):143-8. PubMed ID: 23915911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Significance of S100A10 Expression in Lung Adenocarcinomas.
    Katono K; Sato Y; Jiang SX; Kobayashi M; Saito K; Nagashio R; Ryuge S; Satoh Y; Saegusa M; Masuda N
    Asian Pac J Cancer Prev; 2016; 17(1):289-94. PubMed ID: 26838226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance.
    Nakashima H; Jiang SX; Sato Y; Hoshi K; Matsumoto T; Nagashio R; Kobayashi M; Matsuo Y; Shiomi K; Hayakawa K; Saegusa M; Satoh Y
    Pathol Int; 2015 Apr; 65(4):183-92. PubMed ID: 25684590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases.
    Mori S; Motoi N; Ninomiya H; Matsuura Y; Nakao M; Mun M; Okumura S; Nishio M; Morikawa T; Ishikawa Y
    Pathol Int; 2017 Jan; 67(1):37-44. PubMed ID: 27976463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Subcellular Localization of Maspin in Patients with Pathological Stage IA Lung Adenocarcinoma.
    Ohno T; Kubouchi Y; Wakahara M; Nosaka K; Sakabe T; Haruki T; Miwa K; Taniguchi Y; Nakamura H; Umekita Y
    Anticancer Res; 2018 May; 38(5):3001-3007. PubMed ID: 29715131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chaperone protein L-isoaspartate (D-aspartyl) O-methyltransferase as a novel predictor of poor prognosis in lung adenocarcinoma.
    Saito H; Yamashita M; Ogasawara M; Yamada N; Niisato M; Tomoyasu M; Deguchi H; Tanita T; Ishida K; Sugai T; Yamauchi K
    Hum Pathol; 2016 Apr; 50():1-10. PubMed ID: 26997432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipophilin expression in lung adenocarcinoma is associated with apocrine-like features and poor clinical prognosis: an immunohistochemical study of 328 cases.
    Fujimoto M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Hirata M; Momose M; Date H; Haga H
    Histopathology; 2017 Jan; 70(2):232-241. PubMed ID: 27467545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podoplanin expression in cancer-associated fibroblasts predicts unfavourable prognosis in patients with pathological stage IA lung adenocarcinoma.
    Kubouchi Y; Yurugi Y; Wakahara M; Sakabe T; Haruki T; Nosaka K; Miwa K; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
    Histopathology; 2018 Feb; 72(3):490-499. PubMed ID: 28881047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
    Wu Y; Huang B; Liu Q; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of the monoclonal antibody RP215 to immunoglobulin G in metastatic lung adenocarcinomas is correlated with poor prognosis.
    Liu Y; Liu D; Wang C; Liao Q; Huang J; Jiang D; Shao W; Yin CC; Zhang Y; Lee G; Qiu X
    Histopathology; 2015 Nov; 67(5):645-53. PubMed ID: 25753759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of N-myc downregulated gene 1 in lung adenocarcinoma.
    Dai T; Dai Y; Murata Y; Husni RE; Nakano N; Sakashita S; Noguchi M
    Pathol Int; 2018 Apr; 68(4):224-231. PubMed ID: 29431240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer.
    Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H
    Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic phosphatase Wip1 is a novel prognostic marker for lung adenocarcinoma patient survival.
    Satoh N; Maniwa Y; Bermudez VP; Nishimura K; Nishio W; Yoshimura M; Okita Y; Ohbayashi C; Hurwitz J; Hayashi Y
    Cancer Sci; 2011 May; 102(5):1101-6. PubMed ID: 21281403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma.
    Sakashita M; Sakashita S; Murata Y; Shiba-Ishii A; Kim Y; Matsuoka R; Nakano N; Sato Y; Noguchi M
    Pathol Int; 2018 Nov; 68(11):596-604. PubMed ID: 30320419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma.
    Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM
    Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.